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Cardio/cerebrovascular diseases (CVD) have become one of the major health issue in
our societies. Recent studies show the existing clinical tests to detect CVD are ineffec-
tual as they do not consider different stages of platelet activation or the molecular dy-
namics involved in platelet interactions. Further they are also incapable to consider inter-
individual variability. A physical description of platelets deposition was introduced recently
in Chopard et al. [2017], by integrating fundamental understandings of how platelets in-
teract in a numerical model, parameterized by five parameters. These parameters specify
the deposition process and are relevant for a biomedical understanding of the phenomena.
One of the main intuition is that these parameters are precisely the information needed for
a pathological test identifying CVD captured and that they capture the inter-individual
variability.
Following this intuition, here we devise a Bayesian inferential scheme for estimation of
these parameters, using experimental observations, at different time intervals, on the aver-
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age size of the aggregation clusters, their number per mm2, the number of platelets and the
ones activated per µ` still in suspension. As the likelihood function of the numerical model
is intractable due to the complex stochastic nature of the model, we use a likelihood-free
inference scheme approximate Bayesian computation (ABC) to calibrate the parameters in
a data-driven manner. As ABC requires the generation of many pseudo-data by expensive
simulation runs, we use a high performance computing (HPC) framework for ABC to make
the inference possible for this model.
We consider a collective dataset of 7 volunteers and use this inference scheme to get
an approximate posterior distribution and the Bayes estimate of these five parameters.
The mean posterior prediction of platelet deposition pattern matches the experimental
dataset closely with a tight posterior prediction error margin, justifying our main intuition
and providing a methodology to infer these parameters given patient data. The present
approach can be used to build a new generation of personalized platelet functionality tests
for CVD detection, using numerical modeling of platelet deposition, Bayesian uncertainty
quantification and High performance computing.
Keywords: Platelet deposition, Numerical model, Bayesian inference, Approximate Bayesian
computation, High performance computing
1 Introduction
Blood platelets play a major role in the complex process of blood coagulation, involving
adhesion, aggregation and spreading on the vascular wall to stop a hemorrhage while avoid-
ing the vessel occlusion. Platelets also play a key role in the occurrence of cardio/cerebro-
vascular accidents that constitute a major health issue in our societies. In 2015, Cardio-
vascular diseases (CVD), including disorders of the heart and blood vessels, were the first
cause of mortality worldwide, causing 31% of deaths [Organization, 2015]. Antiplatelet
therapy generally reduces complications in patients undergoing arterial intervention [Stein-
hubl et al., 2002, Mehta et al., 2001]. However, the individual response to dual antiplatelet
therapy is not uniform and consistent studies reported that even under platelets therapy
there were recurrences of atherothrombotic events [Matetzky et al., 2004, Gurbel et al.,
2005, Geisler et al., 2006, Hochholzer et al., 2006, Marcucci et al., 2009, Price et al., 2008,
Sibbing et al., 2009]. In most cases, a standard posology is prescribed to patients, which
does not take into account the inter-individual variability linked to the absorption or the
effectiveness of these molecules. This was supported by a recent study [Koltai et al., 2017],
reporting the high patient-dependency of the response of the antithrombotic drugs. We
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should also note that the evaluation of the response to a treatment by the existing tests is
test-dependent.
Nowadays, platelet function testing is performed either as an attempt to monitor the
efficacy of anti-platelet drugs or to determine the cause of abnormal bleeding or pro-
thrombotic status. The most common method consists of using an optical aggregometer
that measures the transmittance of light passing through plasma rich in platelets (PRP)
or whole blood [Harrison, 2009, Born and Cross, 1963], to evaluate how platelets tend to
aggregate. Other aggregometers determine the amount of aggregated platelets by electric
impedance [Velik-Salchner et al., 2008] or luminescence. In specific contexts, flow cytom-
etry [Michelson et al., 2002] is also used to assess platelet reactivity (VASP test [Bonello
et al., 2009]). Determination of platelet functions using these different existing techniques in
patients undergoing coronary stent implantation have been evaluated in Breet et al. [2010],
which shows the correlation between the clinical biological measures and the occurrence
of a cardiovascular event was null for half of the techniques and rather modest for others.
This may be due to the fact that no current test allows the analysis of the different stages of
platelet activation or the prediction of the in vivo behavior of those platelets [Picker, 2011,
Koltai et al., 2017]. It is well known that the phenomenon of platelet margination (the
process of bringing platelets to the vascular wall) is dependent on the number and shape
of red blood cells and their flow [Piagnerelli et al., 2007], creating different pathologies for
different diseases (e.g., diabetes, End Renal Kidney Disease, hypertension, sepsis). Further,
platelet margination is also known to be influenced by the aspect ratio of surrogate platelet
particles [Reasor et al., 2013]. Although there is a lot of data reported by recent research
works [Maxwell et al., 2007] on the molecules involved in platelet interactions, these studies
indicate that there is a lack of knowledge on some fundamental mechanisms that should
be revealed by new experiments.
Hence, the challenge is to find parameters connecting the dynamic processes of adhesion
and aggregation of platelets to the data collected from the individual patients. Recently, by
combining digital holography microscopy (DHM) and mathematical modeling, Chopard
et al. [2015], Chopard et al. [2017] provided a physical description of the adhesion and
aggregation of platelets in the Impact-R device. A numerical model is developed that
quantitatively describes how platelets in a shear flow adhere and aggregate on a deposition
surface. This is the first innovation in understanding the molecular dynamics involved in
platelet interactions. Five parameters specify the deposition process and are relevant for a
biomedical understanding of the phenomena. One of the main intuition is that the values of
these parameters (e.g., adhesion and aggregation rates) are precisely the information needed
to assess various possible pathological situations and quantify their severity regarding CVD.
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Further, it was shown in Chopard et al. [2017] that, by hand-tuning the parameters of the
mathematical model, the deposition patterns observed for a set of healthy volunteers in the
Impact-R can be reproduced.
Assuming that these parameters can determine the severity of CVD, how do we estimate
the adhesion and aggregation rates of given patients by a clinical test? The determination
of these adhesion and aggregation rates by hand-tuning is clearly not a solution as we need
to search the high-dimensional parameter space of the mathematical model, which becomes
extremely expensive and time consuming. We further notice, this has to be repeated for
each patient and thus requires a powerful numerical approach. In this work, we resolve
the question of estimating the parameters using Bayesian uncertainty quantification. Due
to a complex stochastic nature, the numerical model for platelet deposition does not have
a tractable likelihood function. We use Approximate Bayesian Computation (ABC), a
likelihood-free inference scheme, with an optimal application of HPC [Dutta et al., 2017a]
to provide a Bayesian way to estimate adhesion and aggregation rates given the deposition
patterns observed in the Impact-R of platelets collected from a patient. Obviously, the
clinical applicability of the proposed technique to provide a new platelet function test
remains to be explored, but the numerical model [Chopard et al., 2017] and the proposed
inference scheme here, bring the technical elements together to build a new class of medical
tests.
In section 2 we introduce the necessary background knowledge about the platelet depo-
sition model, whereas Section 3 recalls the concept of Bayesian inference and introduces the
HPC framework of ABC used in this study. Then we illustrate the results of the parameter
determination for platelet deposition model using ABC methodology, collectively for 7 pa-
tients in Section 4. Clearly, the same methodology can be used to determine the parameter
values for each individual patients in a similar manner for a CVD clinical test. Finally, in
section 5 we conclude the paper and discuss its impact from a biomedical perspective.
2 Background and Scientific Relevance
The Impact-R [Shenkman et al., 2008] is a well-known platelet function analyzer. It is a
cylindrical device filled in with whole blood from a donor. Its lower end is a fixed disk,
serving as a deposition surface, on which platelets adhere and aggregate. The upper end
of the Impact-R cylinder is a rotating cone, creating an adjustable shear rate in the blood.
Due to this shear rate, platelets move towards the deposition surface, where they adhere
or aggregate. Platelets aggregate next to already deposited platelets, or on top of them,
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thus forming clusters whose size increase with time. This deposition process has been
successfully described with a mathematical model in Chopard et al. [2015], Chopard et al.
[2017].
The numerical model (coined M in what follows) requires five parameters that specify
the deposition process and are relevant for a bio-medical understanding of the phenomena.
In short, the blood sample in the Impact-R device contains an initial number Nplatelet(0) of
non-activated platelets per µ` and a number Nact−platelet(0) of pre-activated platelets per µ`.
Initially both type of platelets are supposed to be uniformly distributed within the blood.
Due to the process known as shear-induced diffusion, platelets hit the deposition surface.
Upon such an event, an activated platelets will adhere with a probability that depends on
its adhesion rate, pAd, that we would like to determine. Platelets that have adhered on the
surface are the seed of a cluster that can grow due to the aggregation of the other platelets
reaching the deposition surface. We denote with pAg the rate at which new platelets will
deposit next to an existing cluster. We also introduce pT the rate at which platelets deposit
on top of an existing cluster. An important observation made in Chopard et al. [2015],
Chopard et al. [2017] is that albumin, which is abundant in blood, compete with platelet for
deposition. This observation is compatible with results reported in different experimental
settings [Remuzzi and Boccardo, 1993, Fontaine et al., 2009, Sharma et al., 1981]. As a
consequence, the number of aggregation clusters and their size tends to saturate as time
goes on, even though there are still a large number of platelets in suspension in the blood.
To describe this process in the model, two extra parameters, pF , the deposition rate of
albumin, and aT , a factor that accounts for the decrease of platelets adhesion and aggre-
gation on locations where albumin has already deposited, were introduced. The numerical
model is described in full detail in Chopard et al. [2015], Chopard et al. [2017]. Here we
simply repeat the main elements. Due to the mixing in the horizontal direction, it was as-
sumed that the activated platelets (AP), non-activated platelets (NAP) and albumin (Al)
in the bulk can be described by a 1D diffusion equation along the vertical axis z
∂tρ = D∂
2
zρ J = −Dgradρ (1)
where ρ is the density of either AP, NAP or Al, J and D are correspondingly the flux
of particles and the shear induced diffusion. Upon reaching a boundary layer above the
deposition substrate, adhesion and aggregation will take place according to
N˙ = −J(0, t)∆S − pdN(t) (2)
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where N is the number of particles in the boundary layer, ∆S a surface element on the
deposition surface, and pd is the deposition rate, which evolves during time and varies across
the substrate, according to the deposition history. For the deposition process, particles are
considered as discrete entities that can attach to any position of the grid representing
the deposition surface, as sketched in Fig. 1. In this figure, the gray levels illustrate the
density of albumin already deposited in each cell. The picture also illustrates the adhesion,
aggregation, and vertical deposition along the z-axis. On the left panel, activated platelets
(gray side disks) deposit first. Then in the second panel, non-activated platelets (white side
disks) aggregate next to an already formed cluster. Both pre-activated and non-activated
platelets can deposit on top of an existing cluster.
The deposition rules are the following. An albumin that reaches the substrate at time
t deposits with a probability P (t) which depends on the local density ρal(t) of already
deposited Al. We assume that P is proportional to the remaining free space in the cell,
P (t) = pF (ρmax − ρal(t)), (3)
where pF is a parameter and ρmax is determined by the constraint that at most 100,000
albumin particles can fit in a deposition cell of area ∆S = 5 (µm)2, corresponding to the
size of a deposited platelet (obtained as the smallest variation of cluster area observed with
the microscope).
An activated platelet that hits a platelet-free cell deposits with a probability Q, where
Q decreases as the local concentration ρal of albumin increases. We assumed that
Q = pAd exp(−aTρal), (4)
where pAd and aT are parameters. This expression can be justified by the fact that a
platelet needs more free space than an albumin to attach to the substrate, due to their
size difference. In other words, the probability of having enough space for a platelet,
decreases roughly exponentially with the density of albumin in the substrate. This can be
validated with a simple deposition model on a grid, where small and large objects compete
for deposition.
Once an activated platelet has deposited, it is the seed of a new cluster that grows
further due to the aggregation of further platelets. In our model, AP and NAP can deposit
next to already deposited platelets. From the above discussion, the aggregation probability
R is assumed to be
R = pAg exp(−aTρal), (5)
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Figure 1: Sketch of the deposition substrate, discretized in cells of area equal to the surface
of a platelet.
Figure 2: The deposition surface of the Impact-R device after 300 seconds (left) and the
corresponding results of the deposition in the mathematical model (right). Black dots
represent the deposited platelets that are grouped in clusters.
with pAg another parameter.
The above deposition probabilities can also be expressed as deposition rate over the
given simulation time step ∆t = 0.01 s (see Chopard et al. [2017] for details), hence giving
a way to couple the diffusion equation (1) with the 2D discrete deposition process sketched
in Fig. 1. Particles that did not deposit at time t are re-injected in the bulk and contribute
to boundary condition of eq. (1) at z = 0.
To the best of our knowledge, except for Chopard et al. [2015], Chopard et al. [2017]
there is no model in the literature that describes quantitatively the proposed in-vitro ex-
periment. The closest approach is that of Affeld et al. [2013], but albumin is not included,
and the role of pre-activated and non-activated platelets is not differentiated. Also, we
are not aware of any other study than ours that reports both the amount of platelets in
suspension as a function of time and those on the deposition surface.
The validity of the proposed numerical model has been explored in detail in Chopard
et al. [2017]. This validation is based on the fact that the model, using hand-tuned pa-
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rameters can reproduce the time-dependent experimental observations very well. We refer
the readers to Chopard et al. [2017] for a complete discussion. Here we briefly recall the
main elements that demonstrate the excellent agreement of the model and the simulations.
We reproduce Fig. 2 from Chopard et al. [2017], showing the visual similarity between
the actual and simulated deposition pattern. In the validation study, the evolution of the
number of clusters, their average size and the numbers of pre-activated and non-activated
platelets still in suspension matched quantitatively with the experimental measurements
at times 20, 60, 120 and 300 s. In addition, a very good agreement between the simulated
deposition pattern and the experiment was also found by comparing the distributions of
the areas and volumes of the aggregates.
To be noticed, the validation reported in Chopard et al. [2017] was done using manually
estimated parameters. As the main goal of this research is to propose an inference scheme to
learn the parameters in a data-driven manner, a validation for the model and the inference
scheme is reported in Fig. 6 below, using the inferred posterior distribution which also
includes a quantification of prediction error.
For the purpose of the present study, the modelM is parametrized in terms of the five
quantities introduced above, namely the adhesion rate pAd, the aggregation rates pAg and
pT , the deposition rate of albumin pF , and the attenuation factor aT . Some additional pa-
rameters of the model, specifically, the shear-induced diffusion coefficient and the thickness
of the boundary layer [Chopard et al., 2017], are assumed here to be known. Collectively,
we define
θ = (pAg, pAd, pT , pF , aT ).
If the initial values for Nplatelet(0) and Nact−platelet(0), as well as the concentration of albumin
are known from the experiment, we can forward simulate the deposition of platelets over
time using model M for the given values of these parameters θ = θ∗:
M[θ = θ∗]→ {(Sagg−clust(t),Nagg−clust(t),Nplatelet(t),Nact−platelet(t)) , t = 0, . . . , T} . (6)
where Sagg−clust(t),Nagg−clust(t),Nplatelet(t) and Nact−platelet(t) are correspondingly average
size of the aggregation clusters, their number per mm2, the number of non-activated and
pre-activated platelets per µ` still in suspension at time t.
The Impact-R experiments have been repeated with the whole blood obtained from
seven donors and the observations were made at time, 0 sec., 20 sec., 60 sec., 120 sec. and
300 sec. At these five time points, (Sagg−clust(t),Nagg−clust(t),Nplatelet(t),Nact−platelet(t)) are
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measured. Let us call the observed dataset collected through experiment as,
x0 ≡ {(S0agg−clust(t),N0agg−clust(t),N0platelet(t),N0act−platelet(t)) : t = 0 sec., . . . , 300 sec.}.
By comparing the number and size of the deposition aggregates obtained from the in-
vitro experiments with the computational results obtained by forward simulation from
the numerical model (see Fig. 2 for an illustration), the model parameters were manually
calibrated by a trial and error procedure in Chopard et al. [2017]. Due to the complex
nature of the model and high-dimensional parameter space, this manual determination of
the parameter values are subjective and time consuming.
However, if the parameters of the model could be learned more rigorously with an
automated data-driven methodology, we could immensely improve the performance of these
models and bring this scheme as a new clinical test for platelet functions. To this aim, here
we propose to use ABC for Bayesian inference of the parameters. As a result of Bayesian
inference to this context, not only we can automatically and efficiently estimate the model
parameters, but we can also perform parameter uncertainty quantification in a statistically
sound manner, and determine if the provided solution is unique.
3 Bayesian Inference
We can quantify the uncertainty of the unknown parameter θ by a posterior distribution
p(θ|x) given the observed dataset x = x0 . A posterior distribution is obtained, by Bayes’
Theorem as,
p(θ|x) = pi(θ)p(x|θ)
m(x)
, (7)
where pi(θ), p(x|θ) and m(x) = ∫ pi(θ)p(x|θ)dθ are correspondingly the prior distribution on
the parameter θ, the likelihood function, and the marginal likelihood. The prior distribution
pi(θ) ensures a way to leverage the learning of parameters with prior knowledge, which is
commonly known due to the availability of medical knowledge regarding cardio-vascular
diseases. If the likelihood function can be evaluated, at least up to a normalizing constant,
then the posterior distribution can be approximated by drawing a sample of parameter
values from the posterior distribution using (Markov chain) Monte Carlo sampling schemes
[Robert and Casella, 2005]. For the simulator-based models considered in Section 2, the
likelihood function is difficult to compute as it requires solving a very high dimensional
integral. In next Subsection 3.1, we illustrate ABC to perform Bayesian Inference for
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models where the analytical form of the likelihood function is not available in closed form
or not feasible to compute.
3.1 Approximate Bayesian computation
ABC allows us to draw samples from the approximate posterior distribution of parameters
of the simulator-based models in absence of likelihood function, hence to perform approx-
imate statistical inference (eg., point estimation, hypothesis testing, model selection etc.)
in a data-driven manner. In a fundamental Rejection ABC scheme, we simulate from the
model M(θ) a synthetic dataset xsim for a parameter value θ and measure the closeness
between xsim and x0 using a pre-defined discrepancy function d(xsim ,x0). Based on this
discrepancy measure, ABC accepts the parameter value θ when d(xsim ,x0) is less than a
pre-specified threshold value .
As the Rejection ABC scheme is computationally inefficient, to explore the parameter
space in an efficient manner, there exists a large group of ABC algorithms [Marin et al.,
2012]. As pointed in Dutta et al. [2017a], these ABC algorithms, consist of four fundamental
steps:
1. (Re-)sample a set of parameters θ either from the prior distribution or from an already
existing set of parameter samples;
2. For each of the sample from the whole set or a subset, perturb it using the pertur-
bation kernel, accept the perturbed sample based on a decision rule governed by a
threshold or repeat the whole second step;
3. For each parameter sample calculate its weight;
4. Normalize the weights, calculate a co-variance matrix and adaptively re-compute the
threshold for the decision rule.
These four steps are repeated until the weighted set of parameters, interpreted as the
approximate posterior distribution, is ‘sufficiently close’ to the true posterior distribution.
The steps (1) and (4) are usually quite fast, compared to steps (2) and (3), which are the
computationally expensive parts.
These ABC algorithms can be generally classified into two groups based on the deci-
sion rule in step (2). In the first group, we simulate xsim using the perturbed parameter
and accept it if d(xsim ,x0) < , an adaptively chosen threshold. Otherwise we continue
until we get an accepted perturbed parameter. For the second group of algorithms, we do
not have this ‘explicit acceptance’ step but rather a probabilistic one. Here we accept the
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perturbed parameter with a probability that depends on ; if it is not accepted, we keep
the present value of the parameter. The algorithms belonging to the ‘explicit acceptance’
group are RejectionABC [Tavare´ et al., 1997] and PMCABC [Beaumont, 2010], whereas the
algorithms in the ‘probabilistic acceptance’ group are SMCABC [Del Moral et al., 2012],
RSMCABC [Drovandi and Pettitt, 2011], APMCABC [Lenormand et al., 2013], SABC [Al-
bert et al., 2015] and ABCsubsim [Chiachio et al., 2014]. For an ‘explicit acceptance’ to
occur, it may take different amounts of time for different perturbed parameters (more re-
peated steps are needed if the proposed parameter value is distant from the true parameter
value). Hence the first group of algorithms are inherently imbalanced. We notice that an
ABC algorithm with ‘probabilistic acceptance’ do not have the similar issue of imbalance
as a probabilistic acceptance step takes approximately the same amount of time for each
parameter.
The generation of xsim from the model, for a given parameter value, usually takes
up huge amounts of computational resources (e.g. 10 minutes for the platelets deposition
model in this paper). Hence, we want to choose an algorithm with faster convergence to the
posterior distribution with minimal number of required forward simulations. For this work
we choose Simulated Annealing ABC (SABC) which uses a probabilistic decision rule in
Step (2) and needs minimal number of forward simulation than other algorithms as shown
in Albert et al. [2015]. As all tasks of SABC in Step (2) can be run independently, in
our recent work [Dutta et al., 2017a], we have adapted SABC for HPC environment. Our
implementation is available in Python package ABCpy and shows a linear scalability.
We further note that the parallelization schemes in ABCpy were primarily meant for
inferring parameters from models, for which forward simulation takes almost equal time
for any values of θ. Due to the complex stochastic nature of the numerical model, forward
simulation time for different values of θ, can be quite variable. To solve this imbalance in
the forward simulation, additionally to the imbalance reported for ABC algorithms, we use
a new dynamic allocation scheme for MPI developed in Dutta et al. [2017b].
Figure 3: Comparison of work-flow between MPI (left) and dynamic-MPI backend (right).
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Figure 4: Imbalance of ABC algorithms using MPI(straight-forward) (left) and
MPI(dynamic-allocation) backend (right).
3.2 Dynamic Allocation for MPI
Here we briefly discuss how a dynamic allocation strategy for map-reduce provides better
balancing of ABC algorithms compared to a straightforward allocation approach.
In the straightforward approach, the allocation scheme initially distributes m tasks to n
executors, sends the map function to each executor, which in turn applies the map function,
one after the other, to its m/n map tasks. This approach is visualized in Figure 3, where
a chunk represents the set of m/n map tasks. For example, if we want to draw 10, 000
samples from the posterior distribution and we have n = 100 cores available, at each step
of SABC we create groups of 100 parameters and each group is assigned to one individual
core.
On the other hand, the dynamic allocation scheme initially distributes k < m tasks to
the k executors, sends the map function to each executor, which in turn applies it to the
single task available. In contrast to the straightforward allocation, the executor requests a
new map task as soon as the old one is terminated. This clearly results in a better balance
of the work. The dynamic allocation strategy is an implementation of the famous greedy
algorithm for job-shop scheduling, which can be shown to have an overall processing time
(makespan) up to twice as better than the best makespan [Graham, 1966].
This approach is illustrated in Figure 3, reproduced from Dutta et al. [2017b]. The
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unbalanced behavior is apparent if we visualize the run time of the individual map tasks
on each executor. In Figure 4, the individual map tasks processing time is shown for an
ABC algorithm performing inference on a weather prediction model, reported in Dutta
et al. [2017b]. Each row corresponds to an executor (or rank) and each bar corresponds
to the total time spent on all tasks assigned to the respective rank (row) for one map call.
For the straightforward allocation strategy, one can easily verify that most of the ranks
finish their map tasks in half the time of the slowest rank. This clearly leads to large
inefficiencies. Conversely, using the dynamic allocation strategy, the work is more evenly
distributed across the ranks. The unbalancedness is not a problem that can be overcome
easily by adding resources, rather speed-up and efficiency can drop drastically compared
to the dynamic allocation strategy with increasing number of executors. For a detailed
description and comparison, we direct readers to Dutta et al. [2017b].
3.3 Posterior Inference
Using SABC within HPC framework implemented in ABCpy [Dutta et al., 2017a], we draw
Z = 5000 samples approximating the posterior distribution p(θ|x0), while keeping all the
tuning parameters for the SABC fixed at the default values suggested in ABCpy package,
except the number of steps and the acceptance rate cutoff, which was chosen respectively as
30 and 1e−4. The parallelized SABC algorithm, using HPC makes it possible to perform the
computation in 5 hours (using 140 nodes with 36-core of Piz Daint Cray architecture (Intel
Broadwell + NVidia TESLA P100)), which would have been impossible by a sequential
algorithm. To perform SABC for the platelets deposition model, the summary statistics
extracted from the dataset, discrepancy measure between the summary statistics, prior
distribution of parameters and perturbation Kernel to explore the parameter space for
inference are described next.
Summary statistics Given a dataset, x ≡ {(Sagg−clust(t),Nagg−clust(t),Nplatelet(t),Nact−platelet(t)) :
t = 0 sec., . . . , 300 sec.}, we compute an array of summary statistics.
F : x → (µ,σ,ac, c, cc)
defined as following,
- µ = (µ1, µ2, µ3, µ4), mean over time.
- σ = (σ1, σ2, σ3, σ4), variance over time.
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- ac = (ac1, ac2, ac3, ac4), auto-correlation with lag 1.
- c = (c1, c2, c3, c4, c5, c6), correlation between different pairs of variables over time.
- cc = (cc1, cc2, cc3, cc4, cc5, cc6), cross-correlation with lag 1 between different pairs of
variables over time.
The summary statistics, described above, are chosen to capture the mean values, variances
and the intra- and inter- dependence of different variables of the time-series over time.
Discrepancy measure: Assuming the above summary statistics contain the most essen-
tial information about the likelihood function of the simulator-based model, we compute
Bhattacharya-coefficient [Bhattachayya, 1943] for each of the variables present in the time-
series using their mean and variance and Euclidean distances between different inter- and
intra- correlations computed over time. Finally we take a mean of these discrepancies,
such that, in the final discrepancy measure discrepancy between each of the summaries
are equally weighted. The discrepancy measure between two datasets, x1 and x2 can be
specified as,
d(x1,x2) ≡ d(F(x1),F(x2))
=
1
8
4∑
i=1
(1− exp(−ρ(µ1i , µ2i , σ1i , σ2i )))
+
1
2
√√√√ 1
16
(
4∑
i=1
(ac1i − ac2i )2 +
6∑
i=1
(c1i − c2i )2 +
6∑
i=1
(cc1i − cc2i )2
)
,
where ρ(µ1, µ2, σ1, σ2) = 1
4
log
(
1
4
(
σ1
σ2
+ σ
2
σ1
+ 2
))
+1
4
(
(µ1−µ2)2
σ1+σ2
)
is the Bhattacharya-coefficient
[Bhattachayya, 1943] and 0 ≤ exp(−ρ(•)) ≤ 1. Further, we notice the value of the discrep-
ancy measure is always bounded in the closed interval [0, 1].
Prior: We consider independent Uniform distributions for the parameters with a pre-
specified range for each of them, pAg ∼ U(5, 20), pAd ∼ U(50, 150), pT ∼ U(0.5e−3, 3e−3),
pF ∼ U(.1, 1.5) and aT ∼ U(0, 10).
Perturbation Kernel: To explore the parameter space of θ = (pAg, pAd, pT , pF , aT ) ∈
[5, 20] × [50, 150] × [0.5e − 3, 3e − 3] × [.1, 1.5] × [0, 10], we consider a five-dimensional
truncated multivariate Gaussian distribution as the perturbation kernel. SABC inference
scheme centers the perturbation kernel at the sample it is perturbing and updates the
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variance-covariance matrix of the perturbation kernel based on the samples learned from
the previous step.
3.4 Parameter estimation
Given experimentally collected platelet deposition dataset x0 , our main interest is to esti-
mate a value for θ. In decision theory, Bayes estimator minimizes posterior expected loss,
Ep(θ|x0)(L(θ, •)|x0) for an already chosen loss-function L. If we have Z samples (θi)Zi=1 from
the posterior distribution p(θ|x0), the Bayes estimator can be approximated as,
θˆ = arg min
θ
1
M
M∑
i=1
L(θi, θ). (8)
As we consider the Euclidean loss-function L(θ, θˆ) = (θ − θˆ)2 as the loss-function, the
approximate Bayes-estimator can be shown to be θˆ = Ep(θ|x0)(θ) ≈ 1Z
∑Z
i=1 θi.
4 Inference on experimental dataset
The performance of the inference scheme described in Section 3 is reported here, for a
collective dataset created from the experimental study of platelets deposition of 7 blood-
donors. The collective dataset was created by a simple average of
(Sagg−clust(t),Nagg−clust(t),Nplatelet(t),Nact−platelet(t))
over 7 donors at each time-point t. In Figure 5, we show the Bayes estimate (black-
solid) and the marginal posterior distribution (black-dashed) of each of the five parameters
computed using 5000 samples drawn from the posterior distribution p(θ|x0) using SABC.
For comparison, we also plot the manually estimated values of the parameters (gray-solid)
in Chopard et al. [2017]. We notice that the Bayes estimates are in a close proximity of
the manually estimated values of the parameters and also the manually estimated values
observe a significantly high posterior probability. This shows that, through the means
of ABC we can get an estimate or quantify uncertainty of the parameters in platelets
deposition model which is as good as the manually estimated ones, if not better.
Next we do a Posterior predictive check to validate our model and inference scheme.
The main goal here is to analyze the degree to which the experimental data deviate from the
data generated from the inferred posterior distribution of the parameters. Hence we want
to generate data from the model using parameters drawn from the posterior distribution.
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Figure 5: Marginal posterior distribution (black-dashed) and Bayes Estimate (back-solid)
of (pAd, pAg, pT , pF , aT ) for collective dataset generated from of 7 patients. The smoothed
marginal distribution is created by a Gaussian-kernel density estimator on 5000 i.i.d. sam-
ples drawn from the posterior distribution using SABC. The (gray-solid) line indicates the
manually estimated values of the parameters in Chopard et al. [2017].
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To do so, we first draw 100 parameter samples from the inferred approximate posterior
distribution and simulate 100 data sets, each using a different parameter sample. We call
this simulated dataset as the predicted dataset from our inferred posterior distribution
and present the mean predicted dataset (blue-solid) compared with experimental dataset
(black-solid) in Figure 6. Note that since we are dealing with the posterior distribution,
we can also quantify uncertainty in our predictions. We plot the 1/4-th quantile, 3/4-th
quantile (red-dashed), minimum and maximum (gray-dashed) of the predicted dataset at
each timepoints to get a sense of uncertainty in the prediction. Here we see a very good
agreement between the mean predicted dataset and the experimentally observed one, while
the 1/4-th and 3/4-th quantile of the prediction being very tight. This shows a very good
prediction performance of the numerical model of platelet deposition and the proposed
inference scheme.
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Figure 6: Posterior Prediction Check: To validate the numerical model of the platelet
deposition and the inference scheme we perform a posterior prediction check by simulating
100 datasets, each using a different parameter sample drawn from the posterior distribution.
Here, we plot the experimental dataset (black-solid) used for inference, mean predicted
dataset (blue-solid), 1/4-th and 3/4-th quantile (red-dashed), minimum and maximum
(gray-dashed) of the predicted datasets at each timepoints.
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Additionally, to point the strength of having a posterior distribution for the parameters
we compute and show the posterior correlation matrix between the 5 parameters in Figure 7,
highlighting a strong negative correlation between (pF , aT ), strong positive correlations
between (pF , pAg) and (pF , pT ). A detailed investigation of these correlation structure
would be needed to understand them better, but generally they may point towards: a) the
stochastic nature of the considered model for platelet deposition and b) the fact that the
deposition process is an antagonistic or synergetic combination of the mechanisms proposed
in the model.
Note finally that the posterior distribution being the joint probability distribution of
the 5 parameters, we can also compute any higher-order moments, skewness etc. of the
parameters for a detailed statistical investigation of the natural phenomenon.
Figure 7: Posterior correlation matrix of (pAd, pAg, pT , pF , aT ) computed from the 5000 i.i.d.
samples drawn from the posterior distribution using SABC.
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5 Conclusions
Here, we have demonstrated that approximate Bayesian computation (ABC) can be used
to automatically explore the parameter space of the numerical model simulating the depo-
sition of platelets subject to a shear flow as proposed in Chopard et al. [2015], Chopard
et al. [2017]. We also notice the good agreement between the manually tuned parameters
and the Bayes estimates, while saving us from subjectivity and a tedious manual tuning.
This approach can be applied patient per patient, in a systematic way, without the bias
of a human operator. In addition, the approach is computationally fast enough to pro-
vide results in an acceptable time for contributing to a new medical diagnosis, by giving
clinical information that no other known method can provide. The clinical relevance of
this approach is still to be explored and our next step will be to apply our approach at a
personalized level, with a cohort of patients with known pathologies. The possibility of de-
signing new platelet functionality test as proposed here is the result of combining different
techniques: advanced microscopic observation techniques, bottom-up numerical modeling
and simulations, recent data-science development and high performance computing (HPC).
Additionally, the ABC inference scheme provides us with a posterior distribution of the
parameters given observed dataset, which is much more informative about the underly-
ing process. The posterior correlations structure shown in Fig. 7 may not have a direct
biophysical interpretation, though it illustrates some sort of underlying and unexplored
stochastic mechanism for further investigation. Finally we note that, although the manual
estimates achieve a very high posterior probability, they are different from the Bayes esti-
mates learned using ABC. The departure reflects a different estimation of the quality of the
match between experimental observation and simulation results. As the ABC algorithms
are dependent on the choice of the summary statistics and the discrepancy measures, the
parameter uncertainty quantified by SABC in Section 4 or the Bayes estimates computed
are dependent on the assumptions in Section 3.3 regarding their choice. Fortunately there
are recent works on automatic choice of summary statistics and discrepancy measures in
ABC setup [Gutmann et al., 2017], and incorporating some of these approaches in our
inference scheme is a promising direction for future research in this area.
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